Sonelokimab Yields Significant Improvements in Active PsA
Patients receiving sonelokimab experienced higher treatment response in ACR20, ACR50, and PASI90 than those in the placebo group.
Medscape Medical News
source https://www.medscape.com/viewarticle/sonelokimab-yields-significant-improvements-active-psa-early-2024a1000buo?src=rss
Medscape Medical News
source https://www.medscape.com/viewarticle/sonelokimab-yields-significant-improvements-active-psa-early-2024a1000buo?src=rss
Comments
Post a Comment